文献速递肿瘤 PET/CT

原发性前列腺癌中68Ga-PSMA PET/CT测量的PSMA表达的免疫组化验证

Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer.
PubMed 文献 · J Nucl Med · 2017-08-03

回顾性分析31例前列腺癌患者术前68Ga-PSMA PET/CT与前列腺切除标本免疫组化,显示肿瘤SUVmax与PSMA表达显著相关,鉴别正常前列腺与前列腺癌的最佳SUVmax截断值为3.15(敏感度97%、特异度90%、曲线下面积0.987)。

要点

  • 前列腺癌灶平均SUVmax 14.06±15.56显著高于正常前列腺2.43±0.63(P<0.001)。
  • 鉴别正常前列腺与前列腺癌的最佳SUVmax截断值为3.15(敏感度97%、特异度90%)。
  • 多灶性前列腺癌中该截断值敏感度87%、特异度97%。

核心结论

  • 68Ga-PSMA PET/CT的SUVmax与原发性前列腺癌PSMA表达显著相关,能以高敏感度和特异度检出前列腺癌。

研究设计与样本

  • 回顾性分析31例(平均年龄67.2岁)接受前列腺切除术及术前PET的患者数据。
  • PET上前列腺局灶性摄取增高提示肿瘤,在可疑区域勾画感兴趣区生成SUVmax,并在相邻视觉正常前列腺勾画类似感兴趣区。
  • 前列腺癌与正常前列腺均用单克隆抗PSMA抗体(克隆3E6,1:100,M3620)染色。

主要发现

  • 正常前列腺切片(n=31)中位染色强度为轻度、中位染色细胞百分比20%±14.24%、中位免疫反应评分(IRS)为1。
  • 前列腺癌切片(n=31)中位IRS为3、中位染色强度为强、中位染色细胞百分比80%±16.46%。
  • 前列腺癌平均SUVmax(14.06±15.56)显著高于正常前列腺(2.43±0.63;P<0.001)。
  • IRS<2者(n=26)平均SUVmax 2.52±0.64显著低于IRS≥2者(n=36)的12.38±15.02(P<0.001)。
  • 染色细胞<50%的前列腺癌样本(n=30)平均SUVmax 2.81±2.35显著低于≥50%者(n=32)的13.34±15.55(P<0.001);前列腺癌SUVmax与Gleason评分无相关性(P=0.54)。

关键数值与推荐

  • 经62份组织样本免疫组化验证,受试者工作特征曲线分析显示前列腺癌SUVmax最佳截断值为3.15(敏感度97%、特异度90%、曲线下面积0.987)。
  • 应用于多灶性前列腺癌时,该截断值敏感度87%、特异度97%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

68Ga-labeled prostate-specific membrane antigen (68Ga-PSMA) PET/CT has a proven role in staging and restaging of prostate cancer (PCA). The aims of this study were to evaluate the association of intraprostatic 68Ga-PSMA PET/CT findings and PSMA expression in immunohistochemical staining and generate a cutoff value for differentiation between normal prostate (PN) and PCA. Methods: The data of 31 patients (mean age, 67.2 y) who underwent prostatectomy and preoperative PET were retrospectively analyzed. On PET, focally increased uptake in the prostate was suggestive of tumor. A region of interest was placed on the suggestive area to generate an SUVmax; a similar region of interest was placed on adjacent visually PN. Both PCA and PN were stained with monoclonal anti-PSMA antibody (clone 3E6, 1:100, M3620). Results: All intraprostatic PCA lesions on PET could be confirmed histopathologically. In PN sections (n = 31), median staining intensity was mild, median percentage of stained cells was 20% ± 14.24%, and median immunoreactive score (IRS) was 1. In PCA sections (n = 31), median IRS was 3, median staining intensity was strong, and median percentage of stained cells was 80% ± 16.46%. The mean SUVmax (±SD) of PCA (14.06 ± 15.56) was significantly higher than that of PN (2.43 ± 0.63; P < 0.001). Receiver-operating-characteristic curve analyses of the SUVmax of PCA, validated by immunohistochemical staining in 62 tissue samples, showed the best cutoff to be 3.15 (sensitivity, 97%; specificity, 90%; area under curve, 0.987). Applied to multifocal PCA, it resulted in sensitivity and specificity of 87% and 97% respectively. The mean SUVmax of PCA and PN for an IRS of less than 2 (n = 26; 2.52 ± 0.64) was significantly lower than the mean SUVmax for an IRS of 2 or more (n = 36; 12.38 ± 15.02; P < 0.001). The mean SUVmax was significantly lower in PCA samples with fewer than 50% stained cells (n = 30; 2.81 ± 2.35) than in samples with 50% or more (n = 32; 13.34 ± 15.55; P < 0.001). There was no correlation between the SUVmax of PCA and Gleason score (P = 0.54). Conclusion: This study showed that SUVmax on 68Ga-PSMA PET/CT correlates significantly with PSMA expression in primary PCA, enabling the detection of PCA with a high sensitivity and specificity.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Woythal N, Arsenic R, Kempkensteffen C, et al. Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer. J Nucl Med. 2017. PMID: 28775203. doi:10.2967/jnumed.117.195172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。